Kissei Pharmaceutical Co., Ltd.
4547.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥167,726,590 | ¥156,818,970 | ¥121,789,715 | ¥117,823,825 |
| - Cash | ¥25,169,000 | ¥22,894,000 | ¥25,893,000 | ¥30,013,000 |
| + Debt | ¥1,280,000 | ¥1,340,000 | ¥1,490,000 | ¥1,640,000 |
| Enterprise Value | ¥143,837,590 | ¥135,264,970 | ¥97,386,715 | ¥89,450,825 |
| Revenue | ¥88,330,000 | ¥75,579,000 | ¥67,493,000 | ¥65,381,000 |
| % Growth | 16.9% | 12% | 3.2% | – |
| Gross Profit | ¥44,065,000 | ¥37,341,000 | ¥32,375,000 | ¥31,238,000 |
| % Margin | 49.9% | 49.4% | 48% | 47.8% |
| EBITDA | ¥20,250,000 | ¥18,720,000 | ¥17,808,000 | ¥20,261,000 |
| % Margin | 22.9% | 24.8% | 26.4% | 31% |
| Net Income | ¥11,961,000 | ¥11,160,000 | ¥10,528,000 | ¥12,921,000 |
| % Margin | 13.5% | 14.8% | 15.6% | 19.8% |
| EPS Diluted | 274.2 | 246.58 | 228.3 | 280.19 |
| % Growth | 11.2% | 8% | -18.5% | – |
| Operating Cash Flow | ¥6,521,000 | -¥1,677,000 | -¥6,679,000 | ¥1,533,000 |
| Capital Expenditures | -¥4,507,000 | -¥1,833,000 | -¥2,547,000 | -¥1,919,000 |
| Free Cash Flow | ¥2,014,000 | -¥3,510,000 | -¥9,226,000 | -¥386,000 |